PMA device
Clareon Vivity Pro Extended Vision IOLs
Alcon Laboratories, LLC · Extended Depth Of Focus Intraocular Lens (POE, Class III) · First FDA decision Oct 30, 2026, newest Oct 30, 2026Cataract
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
PMA pathway
Device trials
3
Naming "Clareon Vivity Pro"
MAUDE reports
0
Brand "Clareon Vivity Pro", since 2015
PubMed studies
0
Mentioning "Clareon Vivity Pro"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Clareon Vivity Pro Extended Vision IOLs
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
- Clareon Vivity Pro Extended Vision IOLsPMA supplement
P190018-S050 · Decided Oct 30, 2026 · 169 days after receipt · Normal 180 Day Track
Device type: Extended depth of focus intraocular lens (POE) · Ophthalmology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "Clareon Vivity Pro", any status and sponsor, newest update first.
- Contralateral Claims Study of Clareon Vivity ProPivotal-lookingActive, not recruiting
Alcon ResearchNot on our public-company list
NCT07484191 · 165 participants · Start Apr 28, 2026 · Primary completion Oct 28, 2026
Device: Clareon Vivity Pro IOL; Clareon Vivity IOL and 1 more · For: Aphakia; Presbyopia
Sites: Campsie, Australia; Sydney, Australia; Wollongong, Australia · 7 sites in all
Berkeley Eye CenterAcademic, hospital or other
NCT06922084 · 320 participants (planned) · Start Mar 17, 2025 · Primary completion Apr 2027
Device: Clareon PanOptix · For: Cataract
Sites: Plymouth Meeting, Pennsylvania; Houston, Texas
- Visual Outcomes in Patients Contralaterally Implanted With PanOptix Pro and Clareon Vivity Compared to Bilateral Implantation of PanOptix ProPivotal-lookingEnrolling by invitation
Brian ShaferAcademic, hospital or other
NCT07076277 · 346 participants (planned) · Start Aug 5, 2025 · Primary completion Aug 1, 2026
Device: Clareon PanOptix Pro and Clareon Vivity Intraocular Lens; Clareon PanOptix Pro Intraocular Lenses · For: Cataract; Multifocal Intraocular Lens
Sites: Baltimore, Maryland; Alexandria, Minnesota; Bozeman, Montana · 5 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Clareon Vivity Pro", and for the whole product code for context.
This brand
0 reports: 0 malfunction, 0 injury, 0 death
Whole product code POE
6,053 reports: 1,242 malfunction, 4,811 injury, 0 death
Newest reports for this brand
No MAUDE reports name this brand.
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Alcon Laboratories Ireland, Ltd
Z-1269-2022 · Started May 11, 2022
Reason given: Due to device (preloaded intraocular lens) mislabeling, associated with partial mixing of product during overlapping manufacturing runs, and attributed to improper manufacturing line clearance.
Cause as FDA categorized it: Under Investigation by firm · Device type: Intraocular Lens (HQL)
Published research
The most relevant PubMed records for "Clareon Vivity Pro"[tiab]. The summary above synthesizes these.
No PubMed record mentions this device by name.
Other devices of this type
Also filed under product code POE.
- IC-8 Apthera Intraocular Lens (IOL)Acu Focus, Inc. · PMA 2026
- TECNIS Symfony Extended Range Of Vision Intraocular LensJohnson & Johnson Surgical Vision, Inc. · PMA 2023
- TECNIS Symfony PLUS Extended Range of Vision Intraocular Lens (IOL)Johnson & Johnson Surgical Vision, Inc. · PMA 2020
- AcrySof IQ Vivity Extended VisionAlcon Laboratories, Inc. · PMA 2020
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.